Treatment score for hemodynamic status

By exporting arterial pressure waveform data through a hemodynamic monitor, determining the amplitude and trend data of hemodynamic parameters, and generating scores to predict treatment responsiveness, this technology addresses the problem of insufficient monitoring in existing technologies and enables more accurate treatment decision support.

CN115066201BActive Publication Date: 2026-11-10EDWARDS LIFESCIENCES CORP
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202180013754.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-02-24
Filing Date
2021-01-08
Publication Date
2026-11-10
Estimated Expiration
2041-01-08

AI Technical Summary

Technical Problem

The lack of effective methods for monitoring hemodynamic parameters in current technologies leads to serious risks such as insufficient organ perfusion and irreversible ischemic damage for surgical and critically ill patients, and makes it difficult for clinicians to determine treatment measures in a timely manner.

Method used

Arterial pressure waveform data is received by a hemodynamic monitor, and the amplitude and trend data of hemodynamic parameters are exported. Software code is used to determine a score that predicts the patient's response to treatment, and a score representation is provided to support treatment decisions.

Benefits of technology

It provides quantitative scores to predict patient response to treatment, helping medical staff make timely and effective treatment decisions, reducing information processing burden, and improving the accuracy and timeliness of treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115066201B_ABST
    Figure CN115066201B_ABST
Patent Text Reader

Abstract

A system for monitoring a patient's arterial pressure determines a score predicting the patient's responsiveness to treatment. Sensed hemodynamic data, representing the patient's arterial pressure waveform, is received by a hemodynamic monitor. Amplitude and trend data are derived from the hemodynamic data. Based on the amplitude and trend data of the hemodynamic parameters, a score predicting the patient's responsiveness to treatment is determined. A representation of the score is output.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This disclosure generally relates to arterial blood pressure monitoring, and more specifically to determining one or more scores, each of which predicts a patient’s response to a particular treatment. Background Technology

[0002] Arterial blood pressure waveform signals are commonly used to determine hemodynamic parameters such as cardiac output (CO), systemic vascular resistance (SVR), stroke volume (SV), stroke volume variation (SVV), pulse pressure variation (PPV), stroke volume index (SVI), cardiac index (CI), systemic vascular resistance index (SVRI), and maximum rate of rise of arterial pressure (usually referred to as dP / dt). max This can be used to monitor and / or predict important physiological events, or other hemodynamic parameters. For example, an elevated SVV may indicate decreased cardiac preload, which can lead to decreased SV, CO, and arterial blood pressure. Similarly, decreased cardiac afterload can be indicated by a decreased SVR, while dP / dt... max A decrease can indicate a reduced cardiac contractility. If left untreated, these conditions can pose serious risks to surgical and critically ill patients, such as impaired organ perfusion, irreversible ischemic injury, neurological deficits, cardiomyopathy, kidney damage, or other serious medical conditions.

[0003] Therefore, few hospitals lack some form of equipment to monitor one or more of these hemodynamic parameters. For example, in the operating room during major surgery, anesthesiologists or other clinicians are typically responsible for maintaining the patient's mean arterial pressure to ensure adequate perfusion of organs and peripheral tissues. Consequently, the attending clinician will closely monitor such hemodynamic parameters to determine whether to instruct the administration of therapeutic agents. Summary of the Invention

[0004] In one example, a method for monitoring a patient's arterial pressure and determining a score predicting the patient's responsiveness to treatment includes receiving sensed hemodynamic data representing the patient's arterial pressure waveform via a hemodynamic monitor. The method further includes deriving amplitude and trend data of hemodynamic parameters from the hemodynamic data via the hemodynamic monitor, and determining a score predicting the patient's responsiveness to treatment based on the amplitude and trend data of the hemodynamic parameters via the hemodynamic monitor. The method further includes outputting a representation of the score via the hemodynamic monitor.

[0005] In another example, a system for monitoring a patient's arterial pressure and determining a score predicting the patient's responsiveness to treatment includes a hemodynamic sensor, system memory, a user interface, and a hardware processor. The hemodynamic sensor generates hemodynamic data representing the patient's arterial pressure waveform. The system memory stores hemodynamic treatment scoring software code. The hardware processor is configured to execute the hemodynamic treatment scoring software code to derive amplitude and trend data of hemodynamic parameters from the hemodynamic data representing the patient's arterial pressure waveform. The hardware processor is further configured to execute the hemodynamic treatment scoring software code to determine a score predicting the patient's responsiveness to treatment based on the amplitude and trend data of the hemodynamic parameters, and output a representation of the score via the user interface. Attached Figure Description

[0006] Figure 1 This is a perspective view of an example hemodynamic monitor that determines at least one score to predict a patient's responsiveness to treatment.

[0007] Figure 2 This is a perspective view of an example minimally invasive pressure sensor used to sense hemodynamic data representing a patient's arterial pressure.

[0008] Figure 3 This is a perspective view of an example non-invasive sensor used to sense hemodynamic data representing a patient's arterial pressure.

[0009] Figure 4 This is a block diagram illustrating an example hemodynamic monitoring system that determines at least one score to predict a patient's response to treatment.

[0010] Figure 5 This is a flowchart illustrating an example operation for determining at least one score that predicts a patient's responsiveness to treatment.

[0011] Figure 6 This is a block diagram illustrating an example of a hemodynamic monitor with three separate scores, each predicting a patient's response to the corresponding treatment.

[0012] Figure 7 This is a graph illustrating the relationship between hemodynamic parameters derived from arterial pressure waveforms and corresponding treatments.

[0013] Figure 8A This is a chart illustrating an example of a fluid therapy score used to determine the fluid therapy score associated with the therapeutic intravenous delivery of fluid to a patient.

[0014] Figure 8B This is a chart illustrating an example of an amplitude sub-score used to determine a fluid therapy score associated with the delivery of therapeutic intravenous fluid to a patient.

[0015] Figure 8C This is a chart illustrating an example of a trend sub-score used to determine the fluid score associated with the therapeutic intravenous delivery of fluid to a patient.

[0016] Figures 8D-8J This is a graph of the patient's stroke volume change (SVV) versus time, illustrating an example of the best-fit line for the time interval defined by the trend sub-score used to determine the fluid therapy score.

[0017] Figure 8K This is a graph illustrating an example of normalizing the slope of the best-fit line used to determine the trend sub-score for fluid therapy rating.

[0018] Figure 8L This is a chart illustrating an example of applying weights to the normalized slope of the best-fit line and aggregating the weighted normalized slopes to determine the trend sub-scores of the fluid therapy score.

[0019] Figure 8M This is a diagram illustrating an example of how to determine a fluid therapy score based on an amplitude sub-score and a trend sub-score.

[0020] Figure 9A This is a chart illustrating a further example of an amplitude sub-score used to determine the correlation between the delivery of therapeutic intravenous fluid to a patient.

[0021] Figure 9B This is a chart illustrating an example of an amplitude sub-score used to determine the relationship between the administration of therapeutic intravenous inotropic drugs to a patient.

[0022] Figure 9C This is a chart illustrating an example of an amplitude sub-score used to determine the correlation between the administration of a therapeutic intravenous vasopressor to a patient. Detailed Implementation

[0023] As described herein, a hemodynamic monitoring system determines one or more scores to predict a patient's responsiveness to a corresponding treatment, thereby providing one or more quantitative measures that can improve decision support for healthcare professionals in delivering timely and effective therapeutic interventions. The hemodynamic monitoring system implementing the technology of this disclosure determines one or more scores as a combination of amplitude and trend data derived from corresponding hemodynamic parameters. Therefore, the one or more scores are determined based on both the value of the corresponding hemodynamic parameter and its trend over time, for example, to more accurately predict the patient's current and future responsiveness to the corresponding treatment.

[0024] Figure 1 This is a perspective view of the hemodynamic monitor 10, which determines at least one score predicting the patient's response to treatment. (Example) Figure 1As shown, the hemodynamic monitor 10 includes a display 12 that can present a graphical user interface (GUI) including control elements (e.g., graphical control elements) enabling a user to interact with the hemodynamic monitor 10, and output display elements for presenting information to the user (such as at least one score predicting the patient's responsiveness to corresponding treatment). The hemodynamic monitor 10 may also include multiple input and / or output (I / O) connectors configured for wired (e.g., electrical and / or communication) connections to one or more peripheral components (such as one or more hemodynamic sensors), as further described below. For example, as Figure 1 As shown, the hemodynamic monitor 10 may include an I / O connector 14. Although Figure 1 The example illustration shows five individual I / O connectors 14, but it should be understood that in other examples, the hemodynamic monitor 10 may include fewer than five or more I / O connectors. In other examples, the hemodynamic monitor 10 may not include I / O connectors 14 and may instead communicate wirelessly with various peripheral devices.

[0025] As further described below, the hemodynamic monitor 10 includes one or more processors and a computer-readable storage device storing hemodynamic treatment scoring software code. The hemodynamic treatment scoring code is executable to generate at least one score predicting a patient's responsiveness to treatment. For example, the hemodynamic monitor 10 can receive sensed hemodynamic data representing a patient's arterial pressure waveform, such as via one or more hemodynamic sensors connected to the hemodynamic monitor 10 via I / O connector 14. The hemodynamic monitor 10 executes the hemodynamic treatment scoring software code to derive at least one hemodynamic parameter that can indicate a patient's potential hemodynamic condition. For example, reduced cardiac preload, which can lead to decreased stroke volume, cardiac output, arterial blood pressure, and impaired organ perfusion, can be indicated by increased stroke volume variation (SVV) and can be addressed by therapeutic delivery of fluids (e.g., intravenous delivery) such as saline fluids. Reduced cardiac afterload, which can lead to hypotension and potential impairment of organ perfusion, can be indicated by decreased systemic vascular resistance (SVR) and can be addressed by therapeutic delivery of vasopressors (i.e., vasoconstrictors). Decreased cardiac contractility, which can lead to reduced ventricular ejection, cardiac output, arterial blood pressure, and impaired organ perfusion, can be caused by a decrease in the maximum rate of rise of arterial pressure (commonly referred to as dP / dt). max It can be indicated by ) and can be treated by therapeutic delivery of inotrope.

[0026] The hemodynamic monitor 10 executes hemodynamic therapy scoring software code to determine one or more scores that predict a patient's responsiveness to a corresponding treatment. One or more scores may include, for example, a fluid therapy score, which indicates reduced cardiac preload and predicts a patient's responsiveness to therapeutically delivered fluids (indicated by, for example, an increased SVV); a vasopressor therapy score, which indicates reduced cardiac afterload and predicts a patient's responsiveness to therapeutically delivered vasopressors (indicated by, for example, a decreased SVR); and an inotropic therapy score, which indicates reduced cardiac contractility and predicts a patient's responsiveness to therapeutically delivered inotropic drugs (indicated by, for example, a decreased dP / dt). max (to indicate); or other ratings.

[0027] As further described below, the hemodynamic monitor 10 can determine one or more scores as a combination of amplitude and trend data derived from corresponding hemodynamic parameters. Therefore, the hemodynamic monitor 10 can determine one or more scores based on the values ​​of the corresponding hemodynamic parameters and one or more trends of the hemodynamic parameters over time, for example, to more accurately predict a patient's response to a corresponding treatment. The hemodynamic monitor 10 further executes hemodynamic treatment scoring software code to output one (or more) representations of the one or more scores. For example, as further described below, the representation of the scores may include, for example, a display of the scores on a display 12 of the hemodynamic monitor 10, color coding of the scores, a symbolic representation of the scores, an auditory representation of the scores, or other representations of the scores.

[0028] Therefore, the hemodynamic monitor 10 implementing the technology of this disclosure can provide one or more scores that can predict a patient’s responsiveness to corresponding treatments, thereby helping clinicians or other medical personnel to determine timely and effective therapeutic treatments for indicated hemodynamic conditions while reducing the information processing burden on clinicians during events such as surgery or other clinical events.

[0029] Figure 2 This is a perspective view of a hemodynamic sensor 16 that can be attached to a patient to sense hemodynamic data representing the patient's arterial pressure. (See image.) Figure 2 As shown, hemodynamic sensor 16 is an example of a minimally invasive hemodynamic sensor that can be attached to a patient via, for example, a radial artery catheter inserted into the patient's arm. In other examples, hemodynamic sensor 16 can be attached to a patient via a femoral artery catheter inserted into the patient's leg.

[0030] like Figure 2As shown, the hemodynamic sensor 16 includes a housing 18, a fluid inlet port 20, a catheter-side fluid port 22, and an I / O cable 24. The fluid inlet port 20 is configured to connect via tubing or other hydraulic connections to a fluid source, such as a saline bag or other fluid inlet source. The catheter-side fluid port 22 is configured to connect via tubing or other hydraulic connections to a catheter (e.g., a radial artery catheter) inserted into the patient's arm (i.e., a radial artery catheter) or the patient's leg (i.e., a femoral artery catheter). The I / O cable 24 is configured to connect via, for example, one or more I / O connectors 14 (… Figure 1 The hemodynamic sensor 16 is connected to the hemodynamic monitor 10. The housing 18 of the hemodynamic sensor 16 encloses one or more pressure transducers, communication circuitry, processing circuitry, and corresponding electronic components to sense fluid pressure corresponding to the patient's arterial pressure, which is transmitted to the hemodynamic monitor 10 via I / O cable 24. Figure 1 ).

[0031] In operation, a fluid column (e.g., saline solution) is introduced from a fluid source (e.g., a saline bag) through a hemodynamic sensor 16 via a fluid inlet port 20 toward a catheter inserted into the patient's body, to a catheter-side fluid port 22. Arterial pressure is transmitted through the fluid column to a pressure sensor located within the housing 16, which senses the pressure of the fluid column. The hemodynamic sensor 16 converts the sensed pressure of the fluid column into an electrical signal via a pressure transducer and outputs the corresponding electrical signal to the hemodynamic monitor 10 via an I / O cable 24. Figure 1 Therefore, hemodynamic sensor 16 transmits analog sensor data (or a digital representation of the analog sensor data) representing a substantially continuous beat-by-beat monitoring of the patient's arterial pressure to hemodynamic monitor 10. Figure 1 ).

[0032] Figure 3 This is a perspective view of the hemodynamic sensor 26, which is used to sense hemodynamic data representing the patient's arterial pressure. (See image.) Figure 3 As shown, hemodynamic sensor 26 is an example of a non-invasive hemodynamic sensor that can be attached to a patient via one or more finger cots to sense data representing the patient's arterial pressure. Figure 3 As shown, the hemodynamic sensor 26 includes an inflatable finger cot 28 and a cardiac reference sensor 30. The inflatable finger cot 28 includes an inflatable blood pressure cuff configured to inflate and deflate, as controlled by a pressure controller (not shown) pneumatically connected to the inflatable finger cot 28. The inflatable finger cot 28 also includes an optical (e.g., infrared) transmitter and an optical receiver electrically connected to the cardiac reference sensor 30 to measure changes in the volume of arteries in the finger.

[0033] During operation, the pressure controller continuously adjusts the pressure within the finger sleeve to maintain a constant volume of artery in the finger (i.e., the empty volume of the artery), as measured by the cardiac reference sensor 30 via the optical transmitter and optical receiver of the inflatable finger sleeve 28. The pressure applied by the pressure controller to continuously maintain the empty volume represents the blood pressure in the finger and is transmitted by the pressure controller to the cardiac reference sensor 30. The cardiac reference sensor 30 converts the pressure signal representing the blood pressure in the finger into hemodynamic data representing the patient's arterial pressure waveform, which is transmitted via, for example, I / O connector 14 ( Figure 1 Transmitted to hemodynamic monitor 10 ( Figure 1 Therefore, the hemodynamic sensor 26 transmits sensor data representing essentially continuous beat-by-beat monitoring of the patient's arterial pressure.

[0034] Figure 4 This is a block diagram of a hemodynamic monitoring system 32 that determines one or more scores to predict a patient's response to a corresponding treatment. (Example) Figure 4 As shown, the hemodynamic monitoring system 32 includes a hemodynamic monitor 10 and a hemodynamic sensor 34. The hemodynamic monitoring system 32 can be implemented in patient care environments, such as ICUs, ORs, or other patient care environments. Figure 4 As shown, the patient care environment may include a patient 36 and a healthcare worker 38 trained to utilize the hemodynamic monitoring system 32.

[0035] As mentioned above Figure 1 As described, the hemodynamic monitor 10 can be an integrated hardware unit, for example, including a system processor 40, system memory 42, a display 12, and an analog-to-digital converter (ADC) 44. In other examples, any one or more components of the hemodynamic monitor 10 and / or the described functions can be distributed across multiple hardware units. For example, in some examples, the display 12 can be a separate display device that is remote from and operatively coupled to the hemodynamic monitor 10. Generally, although in Figure 4 The examples are illustrated and described as integrated hardware units, but it should be understood that the hemodynamic monitor 10 may include any combination of devices and components that are electrically, communicatively, or otherwise operatively connected to perform the functions attributed herein to the hemodynamic monitor 10.

[0036] like Figure 4As shown, system memory 42 stores hemodynamic treatment scoring software code 48. Hemodynamic treatment scoring software code 48 includes a hemodynamic parameter module 50 and a treatment scoring module 52. Display 12 provides a user interface 54, which includes control elements 56 that enable the user to interact with the hemodynamic monitor 10 and / or other components of the hemodynamic monitoring system 32. Figure 4 As shown, the user interface 54 may also provide graphical and / or auditory outputs 58, which display or otherwise present to healthcare professionals (e.g., healthcare workers 38) one or more scores predicting the patient 36’s responsiveness to corresponding treatment.

[0037] A hemodynamic sensor 34 may be attached to a patient 36 to sense hemodynamic data representing the arterial pressure waveform of the patient 36. The hemodynamic sensor 34 is operatively connected to a hemodynamic monitor 10 (e.g., via a wired or wireless connection, or both, and / or a communication connection) to provide the sensed hemodynamic data to the hemodynamic monitor 10. In some examples, the hemodynamic sensor 34 provides the hemodynamic data representing the arterial pressure waveform of the patient 36 as an analog signal to the hemodynamic monitor 10, which is converted by an ADC 44 into digital hemodynamic data representing the arterial pressure waveform. In other examples, the hemodynamic sensor 34 may provide the sensed hemodynamic data to the hemodynamic monitor 10 in digital form, in which case the hemodynamic monitor 10 may not include or utilize an ADC 44. In other examples, the hemodynamic sensor 34 may provide the hemodynamic data representing the arterial pressure waveform of the patient 36 as an analog signal, which is analyzed by the hemodynamic monitor 10 in its analog form.

[0038] The hemodynamic sensor 34 can be a non-invasive or minimally invasive sensor attached to the patient 36. For example, the hemodynamic sensor 34 can take the form of a minimally invasive hemodynamic sensor 16. Figure 2 ), non-invasive hemodynamic sensor 26 ( Figure 3 This can be in the form of a hemodynamic sensor 34, or other minimally invasive or non-invasive hemodynamic sensors. In some examples, the hemodynamic sensor 34 can be non-invasively attached to the limbs of the patient 36, such as the wrist, arm, fingers, ankle, toes, or other extremities. Therefore, the hemodynamic sensor 34 can take the form of a small, lightweight, and comfortable hemodynamic sensor suitable for prolonged wear by the patient 36 to provide essentially continuous beat-by-beat monitoring of the patient 36's arterial pressure over extended periods of time, such as minutes or hours.

[0039] In some examples, the hemodynamic sensor 34 can be configured to sense the arterial pressure of the patient 36 in a minimally invasive manner. For example, the hemodynamic sensor 34 can be attached to the patient 36 via a radial artery catheter inserted into the patient 36's arm. In other examples, the hemodynamic sensor 34 can be attached to the patient 36 via a femoral artery catheter inserted into the patient 36's leg. Such minimally invasive techniques can similarly enable the hemodynamic sensor 34 to provide essentially continuous beat-by-beat monitoring of the patient 36's arterial pressure over extended time periods, such as minutes or hours.

[0040] System processor 40 is configured to execute hemodynamic treatment scoring software code 48, which implements hemodynamic parameter model 50 and treatment scoring module 52 to generate one or more scores predicting the responsiveness of patient 36 to corresponding treatments. Examples of system processor 40 may include any one or more of a microprocessor, controller, digital signal processor (DSP), application-specific integrated circuit (ASIC), field-programmable gate array (FPGA), or other equivalent discrete or integrated logic circuits.

[0041] System memory 42 can be configured to store information within hemodynamic monitor 10 during operation. In some examples, system memory 42 is described as a computer-readable storage medium. In some examples, the computer-readable storage medium may include a non-transitory medium. The term "non-transitory" may indicate that the storage medium is not embodied in a carrier wave or propagating signal. In some examples, the non-transitory storage medium may (e.g., in RAM or cache) store data that may change over time. System memory 42 may include volatile and non-volatile computer-readable memory. Examples of volatile memory may include random access memory (RAM), dynamic random access memory (DRAM), static random access memory (SRAM), and other forms of volatile memory. Examples of non-volatile memory may include, for example, magnetic hard disks, optical disks, flash memory, or electrically programmable memory (EPROM) or electrically erasable programmable memory (EEPROM).

[0042] Display 12 may be a liquid crystal display (LCD), a light-emitting diode (LED) display, an organic light-emitting diode (OLED) display, or other display devices suitable for providing information to a user in graphical form. User interface 54 may include graphical and / or physical control elements that enable user input to interact with the hemodynamic monitor 10 and / or other components of the hemodynamic monitoring system 32. In some examples, user interface 54 may take the form of a graphical user interface (GUI) that presents graphical control elements on, for example, a touch-sensitive and / or presence-sensitive display screen of display 12. In such examples, user input may be received in the form of gesture input, such as touch gestures, scroll gestures, zoom gestures, or other gesture inputs. In some examples, user interface 54 may take the form of physical control elements and / or include physical control elements, such as physical buttons, keys, knobs, or other physical control elements configured to receive user input to interact with components of the hemodynamic monitoring system 32.

[0043] The following is combined Figure 5 The flowchart further describes the operation of the hemodynamic monitoring system 32 in generating one or more risk scores that predict the patient 36's responsiveness to corresponding treatment. For example... Figure 5 As shown, the hemodynamic monitor 10 receives sensed hemodynamic data representing the arterial pressure waveform of patient 36 (step 60). For example, the hemodynamic sensor 34 can sense the hemodynamic data representing the arterial pressure waveform of patient 36. The hemodynamic sensor 34 can provide the hemodynamic data (e.g., as analog sensor data) to the hemodynamic monitor 10. The ADC 44 can convert the analog hemodynamic data into digital hemodynamic data representing the arterial pressure waveform of patient 36.

[0044] Hemodynamic monitor 10 derives amplitude data of hemodynamic parameters from hemodynamic data representing the arterial pressure waveform of patient 36 (step 62). For example, as further described below, hemodynamic monitor 10 may execute hemodynamic therapy scoring software code 48 to implement hemodynamic parameter module 50 to derive hemodynamic parameter data from the arterial pressure waveform data. Such hemodynamic parameter data may include, for example, SVV data, SVR data, dP / dt. maxAny one or more of the data or other hemodynamic parameter data. The amplitude data of one or more hemodynamic parameters can take the form, for example, derived values ​​of the hemodynamic parameters over time. For example, as mentioned above, an elevated SVV can indicate reduced precardia, which can be addressed by a therapeutic delivery fluid. The hemodynamic parameter module 50 can derive time-varying SVV amplitude data from hemodynamic data representing the arterial pressure waveform of patient 36; such SVV amplitude data can be used to determine a score predicting the patient 36's responsiveness to a therapeutic delivery fluid (such as saline). Similarly, the hemodynamic parameter module 50 can derive time-varying SVR amplitude data, which can be used to determine a score predicting the patient 36's responsiveness to therapeutic delivery vasopressors (such as norepinephrine, dopamine, and epinephrine, or other vasoconstrictors). The hemodynamic parameter module 50 can derive time-varying dP / dt. max Amplitude data, which can be used to determine a score predicting a patient's response to 36 therapeutic delivery inotropic agents (such as dobutamine, milrinone, amrinone, calcium sensitizers, or other inotropic agents).

[0045] Hemodynamic monitor 10 exports trend data of hemodynamic parameters (step 64). For example, hemodynamic monitor 10 may execute hemodynamic therapy scoring software code 48 to implement hemodynamic parameter module 50 to export trend data of hemodynamic parameters. Such trend data may take the form, for example, best-fit lines (or multiple best-fit lines) of hemodynamic parameter data associated with one or more defined time intervals, as further described below. Hemodynamic parameter module 50 may export SVV trend data (or PPV trend data, or SV trend data, or SVI trend data), SVR trend data (or SVRI trend data), and dP / dt. max Any one or more of the following trend data (or CI trend data or CO trend data), SVV trend data (or PPV trend data, or SV trend data, or SVI trend data) can be used to determine a score predicting a patient's 36-day response to a therapeutic delivery fluid, SVR trend data (or SVRI trend data) can be used to determine a score predicting a patient's 36-day response to a therapeutic delivery vasopressor, dP / dt max Trend data (or CI trend data or CO trend data) can be used to determine a score that predicts a patient's responsiveness to 36 therapeutic delivery inotropic drugs.

[0046] Hemodynamic monitor 10 determines an amplitude sub-score based on amplitude data of derived hemodynamic parameters (step 66). For example, as further described below, hemodynamic monitor 10 can execute hemodynamic treatment scoring software code 48 to implement treatment scoring module 52 to determine the amplitude sub-score as a normalized value ranging between a lower limit normalized threshold (e.g., a lower limit threshold value of zero) at the lower limit amplitude threshold of the amplitude data and an upper limit normalized threshold (e.g., an upper limit threshold value of one) at the upper limit amplitude threshold of the amplitude data. The lower limit and upper limit amplitude thresholds of the amplitude data can be functions of hemodynamic parameters. For example, as further described below, the lower limit amplitude threshold for SVV parameter data can be 7% (e.g., corresponding to a lower limit normalized value threshold of zero), and the upper limit amplitude threshold for SVV parameter data can be 13% (e.g., corresponding to an upper limit normalized value threshold of one). Treatment scoring module 52 can determine the amplitude sub-score for SVV parameter data, SVR parameter data, and dP / dt. max Any one or more magnitude sub-ratings in the parameter data (e.g., as normalized values).

[0047] Hemodynamic monitor 10 determines a trend sub-score based on trend data of derived hemodynamic parameters (step 68). For example, as further described below, hemodynamic monitor 10 can execute hemodynamic treatment scoring software code 48 to implement treatment scoring module 52 to determine the trend sub-score as an aggregation of one or more weighted (and in some examples, normalized) best-fit lines associated with one or more defined time intervals of hemodynamic parameter data. Treatment scoring module 52 can be applied to SVV parameter data, PPV parameter data, SV parameter data, SVI parameter data, SVR parameter data, SVRI parameter data, CI parameter data, and dP / dt. max Any one or more defined trend sub-scores in the parameter data.

[0048] Hemodynamic monitor 10 determines one or more scores based on amplitude sub-scores and associated trend sub-scores, each score predicting the patient's responsiveness to the corresponding treatment (step 70). For example, hemodynamic monitor 10 may execute hemodynamic treatment scoring software code 48 to implement treatment scoring module 52 to determine one or more scores as a combination of amplitude sub-scores and associated trend sub-scores, such as the product of amplitude sub-scores and trend sub-scores.

[0049] The hemodynamic monitor 10 outputs a representation of each of one or more scores (step 72). For example, as further described below, the hemodynamic monitor 10 may (e.g., via display 12, one or more speaker devices or other output devices) output a numerical representation of each score, a color-coded numerical representation of each score, a symbolic representation of each score, an auditory representation of each score, or any one or more other representations of each score (or other multiple representations).

[0050] Therefore, the hemodynamic monitor 10 implementing the technology of this disclosure provides one or more scores predicting the responsiveness of patient 36 to corresponding treatments, thereby reducing the information processing burden on attending physicians and providing decision support for these physicians to deliver therapeutic treatments in a timely and effective manner in response to indicated hemodynamic conditions. Furthermore, the provided scores (determined not only by amplitude data but also by trend data of derived hemodynamic parameters) help indicate the patient's future responsiveness to corresponding treatments, thereby further enhancing the decision support provided by the corresponding scores.

[0051] Figure 6 This is a block diagram illustrating another example of a hemodynamic monitor 10, showing three separate scores, each predicting a patient's responsiveness to the corresponding treatment. Figure 6 As shown, the hemodynamic monitor 10 displays the fluid score 74, vasopressor score 76, and inotropic agent score 78 on the display 12. The fluid score 74 (in...) Figure 6 The example with a value of "94" represents a score determined by hemodynamic monitor 10 based on SVV (or PPV, or SVI, or SV) parameter data and predicting the patient's responsiveness to therapeutic delivery fluids. Vascular vasopressor score 76 (in...) Figure 6 The example with a value of "56" represents a score determined by hemodynamic monitor 10 based on SVR parameter data and predicting the patient's responsiveness to therapeutic delivery of vasopressors. The inotropic drug score of 78 (in...) Figure 6 The example with the value "31" indicates that the hemodynamic monitor 10 is based on dP / dt. max Parametric data (or CO parameter data or CI parameter data) determined and predicted patient responsiveness scores to 36 therapeutic delivery inotropic drugs. Although Figure 6 The example illustrations and descriptions depict three separate scores (74, 76, and 78). It should be understood that in other examples, the hemodynamic monitor 10 may determine and provide (e.g., display) any one or more of the fluid score 74, the vasopressor score 76, and the inotropic drug score 78.

[0052] like Figure 6As shown, each of the fluid score 74, vasopressor score 76, and inotropic drug score 78 has a value ranging between a lower threshold of zero and an upper threshold of one hundred. In other examples, the hemodynamic monitor 10 may determine and / or provide scores 74, 76, and 78 as values ​​ranging between other lower and upper threshold values, such as between zero and one, between negative one and one, between zero and ten, or any other defined range. Similarly, although in Figure 6 In one example, the upper limit numerical threshold (e.g., one hundred) corresponds to a prediction of high responsiveness to the corresponding treatment, and the lower limit numerical threshold (e.g., zero) corresponds to a prediction of low responsiveness to the corresponding treatment. In other examples, this correspondence between predicted responsiveness and the lower and upper limit numerical thresholds can be reversed (e.g., the lower limit threshold corresponds to a prediction of high responsiveness, and the upper limit threshold corresponds to a prediction of low responsiveness).

[0053] In some examples, the hemodynamic monitor 10 may display scores 74, 76, and 78 as color-coded scores based on the values ​​of the corresponding scores. For example, the hemodynamic monitor 10 may display fluid score 74 as a first color (e.g., green) in response to determining that fluid score 74 falls within a first range of values ​​corresponding to low predictive responsiveness of patient 36 to therapeutic delivery fluid (e.g., between values ​​of zero and forty, or other ranges). Similarly, the hemodynamic monitor 10 may display fluid score 74 as a second color (e.g., yellow) in response to determining that fluid score 74 falls within a second range of values ​​corresponding to moderate predictive responsiveness of patient 36 to therapeutic delivery fluid (e.g., between values ​​of forty and eighty, or other ranges). The hemodynamic monitor 10 may display fluid score 74 as a third color (e.g., red) in response to determining that fluid score 74 falls within a third range of values ​​corresponding to high predictive responsiveness of patient 36 to therapeutic delivery fluid (e.g., between values ​​of eighty and one hundred, or other ranges). It should be understood that the example ranges described in this article (i.e., the first range of 0 to 40, the second range of 40 to 80, and the third range of 80 to 100) are merely illustrative and may vary (and in some examples, be adjustable) depending on the expected sensitivity of the score to graphically show the patient’s predictive response to the corresponding treatment.

[0054] In some examples, the hemodynamic monitor 10 may invoke a sensory alarm in response to determining that any one or more of scores 74, 76, and 78 meet threshold alarm criteria, such as criteria indicating a high predictive responsiveness of patient 36 to a corresponding treatment (e.g., a value greater than 80, or other threshold criteria). Sensory alarms may take the form of visual alarms, auditory alarms, tactile alarms, or other types of sensory alarms. For example, a sensory alarm may be invoked as a flashing and / or color graphic displayed on display 12, a warning sound (such as an alarm or repetitive tone), a tactile alarm configured to vibrate the hemodynamic monitor 10 or otherwise deliver a bodily impulse perceptible to the attending healthcare worker or other user, or any combination of other types of sensory alarms.

[0055] Therefore, the hemodynamic monitor 10 can provide one or more scores to indicate to clinicians or other medical personnel the presence and identity of a treatment (or treatments) that predicts the patient's response. Thus, the hemodynamic monitor 10 can facilitate decisions by attending physicians to provide timely and effective therapeutic treatment to stabilize or prevent potential hemodynamic conditions in patients.

[0056] Figure 7 This is a graph illustrating the relationship between hemodynamic parameter 80 and the corresponding treatment 82. (For example...) Figure 7 As shown, among other things, hemodynamic parameters 80 may include SVV, PPV, SVI, SV, SVR, SVRI, and dP / dt. max CO and CI. Among other things, treatment 82 may include therapeutic delivery fluids, vasopressors, and inotropic agents. For example... Figure 7 As shown and as described above, elevated SVV and / or PPV (or decreased SVI or SV) can indicate reduced cardiac preload, which can be addressed by correspondingly administering a therapeutic fluid to the patient. Decreased SVR and / or SVRI can indicate reduced cardiac afterload, which can be addressed by correspondingly administering a vasopressor to the patient. Decreased dP / dt max CO and / or CI can indicate reduced cardiac contractility, which can be addressed by correspondingly administering inotropic drugs to the patient.

[0057] Figures 8A-8M The illustration shows the hemodynamic monitor 10 ( Figure 1 , Figure 4 and Figure 6 Examples of fluid therapy scores used to predict a patient's responsiveness to therapeutic delivery fluids. Although Figures 8A-8M Examples are described below regarding fluid therapy scores; it should be understood that... Figures 8A-8MThe examples are applicable to other treatment scores, such as the vasopressor treatment score predicting patient responsiveness to therapeutically delivered vasopressors and the inotropic treatment score predicting patient responsiveness to therapeutically delivered inotropic agents. Furthermore, although the following description pertains to fluid therapy scores based on SVV parameter data... Figures 8A-8M The example should be understood as follows: Figures 8A-8M The example is applicable to determining a fluid therapy score based on any one or more of the SVV, PPV, SVI, and SV parameter data.

[0058] like Figure 8A As shown, the hemodynamic monitor 10 can determine the score predicting a patient's response to a corresponding treatment as an amplitude sub-score based on amplitude and trend data of hemodynamic parameters (in... Figure 8A The diagram shows "absolute score" and trend sub-score (in the figure). Figure 8A The diagram shows a combination of "trend scores". The hemodynamic monitor 10 can determine any one or more scores that predict a patient's response to any one or more corresponding treatments. Figure 8A In the example, hemodynamic monitor 10 will score the fluid therapy (in Figure 8A The figure in the middle (represented as "fluid score") is determined as a fluid amplitude sub-score (in... Figure 8A The diagram shows the "absolute fluid score" and the fluid trend sub-score (in...). Figure 8A The diagram shows the product of the "fluid trend score".

[0059] Figure 8B The diagram illustrates the method used to determine Figure 8A An example of a fluid amplitude sub-rating, which is in Figure 8B The diagram in the middle shows the "absolute fluid score". For example... Figure 8B As shown, the hemodynamic monitor 10 can determine the fluid amplitude sub-score as a normalized value between a lower normalized threshold with a value of zero at the lower amplitude threshold of 7% SVV and an upper normalized threshold with a value of one at the upper amplitude threshold of 13%, although other normalized thresholds and amplitude thresholds are also possible.

[0060] exist Figure 8B In the example, the hemodynamic monitor 10 performs linear interpolation between the lower limit normalized threshold and the upper limit normalized threshold to determine amplitudes greater than the lower limit threshold (e.g., Figure 8B 7% in the example) and below the upper limit magnitude threshold (e.g., Figure 8BIn the example, the fluid amplitude sub-score is used to determine the intermediate SVV values ​​(13% in some cases). In other examples, the hemodynamic monitor 10 does not require linear interpolation but can determine the fluid amplitude sub-score based on nonlinear interpolation. As further described below, the hemodynamic monitor 10 utilizes the fluid amplitude sub-score to determine a fluid score that predicts the patient's responsiveness to therapeutic fluid delivery.

[0061] Figure 8C The diagram illustrates the method used to determine Figure 8A An example of a fluid trend sub-rating. For example... Figure 8C As shown, the hemodynamic monitor 10 can determine a fluid trend sub-score (in the case of a hemodynamic parameter associated with one or more defined time intervals, which in this example is SVV, corresponding to the therapeutic delivery fluid) based on the aggregation of the normalized slope of the best-fit line. Figure 8C The diagram in the middle is for "fluid trend score". For example, the hemodynamic monitor 10 can determine the fluid trend sub-score according to the following equation:

[0062]

[0063] Where n is the number of defined time intervals, the normalized slope value is the normalized slope of the best-fit line of the hemodynamic parameters associated with the corresponding defined time interval, and the window weight is a weighted value associated with the corresponding time interval.

[0064] Figures 8D-8J The illustration shows an example of using a best-fit line associated with five defined time intervals of SVV parameter data to determine trend data. Figure 8D The diagram illustrates a graph of example SVV parameter data as a percentage of SVV, used as a function of time (in minutes). Figure 8D As shown, the hemodynamic monitor 10 can use the initial assessment point 84 to assess SVV parameters. Figure 8D In the example, the initial evaluation point 84 corresponds to the percentage of SVV (10% SVV) at time 676 minutes. Although in Figure 8D In the example, initial assessment point 84 was acquired at 676 minutes. This is not the latest time when SVV data was available, but it should be understood that initial assessment point 84 could be acquired at any time when SVV data was available. For example, in some examples, the initial assessment point could be determined as the latest time when hemodynamic parameter data (SVV in this example) became available, so that as new hemodynamic parameter data became available, Figures 8D-8J The example operations can be performed on an iterative basis.

[0065] Figure 8EThe diagram illustrates the SVV parameter data as a graph, and shows multiple defined time intervals for the SVV data. Specifically, Figure 8E The example illustration shows five separate time intervals: interval I1, which includes SVV data for the previous minute (i.e., with respect to minute 676 corresponding to the initial evaluation point 84) and includes SVV data from minute 675 to minute 676; interval I2, which includes SVV data for the previous two minutes and includes SVV data from minute 674 to minute 676; interval I3, which includes SVV data for the previous three minutes and includes SVV data from minute 673 to minute 676; interval I4, which includes SVV data for the previous four minutes and includes SVV data from minute 672 to minute 676; and interval I5, which includes SVV data for the previous five minutes and includes SVV data from minute 671 to minute 676.

[0066] Although Figure 8E The example illustration shows five individual time intervals (I1-I5), but in other examples, the hemodynamic monitor 10 can utilize any one or more time intervals. For example, in some examples, the hemodynamic monitor 10 can utilize a single defined time interval to derive trend data for hemodynamic parameters (e.g., SVV). In other examples, the hemodynamic monitor 10 can utilize two, three, four, five, or more defined time intervals to derive trend data. Additionally, although... Figure 8E The examples illustrate the use of time intervals with durations of integer minutes, but in all examples, hemodynamic monitor 10 does not need to utilize integer minutes. For example, hemodynamic monitor 10 can use defined time intervals of ten seconds, fifteen seconds, thirty seconds, ninety seconds, or any other time interval with non-integer minutes (or seconds) to derive trend data for hemodynamic parameters.

[0067] Figure 8F The illustration shows an example of SVV trend data determined by the hemodynamic monitor 10 within time interval I1. (Example:) Figure 8F As shown, the hemodynamic monitor 10 can use SVV data included in time interval I1 (e.g., SVV data from the previous minute) to determine the trend data of SVV as the slope of the best-fit line through the SVV data included in interval I1 (e.g., using linear regression), although other linear or nonlinear trend determinations are possible, such as by using a polynomial trend line, an exponential trend line, or other trend determinations. Figure 8F In the example, the hemodynamic monitor 10 determines the value with a positive two by the slope of the best-fit line of the SVV data included in the interval I1.

[0068] Figures 8G-8J The illustration shows an example of trend data for SVV determined by hemodynamic monitor 10 at intervals I2-I5. For example, in Figure 8G In the example, the hemodynamic monitor 10 determines the slope of the best-fit line with a positive value of 1.1 based on the SVV data included in interval I2 (i.e., SVV data from minute 674 to minute 676). Figure 8H In this process, the hemodynamic monitor 10 determines the slope of the best-fit line of the SVV data included in interval I3 as having a value of positive 0.3. Figure 8I In the example, the hemodynamic monitor 10 determines the slope of the best-fit line of the SVV data included in interval I4 as having a value of -0.15 (i.e., -0.15). Figure 8J In this process, the hemodynamic monitor 10 determines the slope of the best-fit line of the SVV data included in interval I5 as having a value of -0.2 (i.e., -0.2).

[0069] Figure 8K The illustration shows an example of the determined slope values ​​determined by normalization of the hemodynamic monitor 10 and its association with intervals I1-I5. (See example...) Figure 8K As shown, the hemodynamic monitor 10 can normalize each of a plurality of determined slope values ​​to produce a plurality of normalized slope values ​​ranging, for example, between a positive one (i.e., +1) and a negative one (i.e., -1), although other normalization ranges are also possible. In some examples, the hemodynamic monitor 10 can normalize the plurality of determined slope values ​​based on previous patient data. In other examples, the hemodynamic monitor 10 can normalize the plurality of determined slope values ​​based on the range of determined slope values ​​relative to the range of normalized values.

[0070] exist Figure 8K In the example, hemodynamic monitor 10 normalizes the slope determined by the best-fit line of the SVV data included in interval I1 to a value with a positive one (i.e., +1). Hemodynamic monitor 10 normalizes the slope determined by the best-fit line of the SVV data included in interval I2 to a value with a positive one (i.e., +1). Hemodynamic monitor 10 normalizes the slope determined by the best-fit line of the SVV data included in interval I3 to a value with a positive 0.76 (i.e., 0.76). Hemodynamic monitor 10 normalizes the slope determined by the best-fit line of the SVV data included in interval I4 to a value with a negative 0.34 (i.e., -0.34). Hemodynamic monitor 10 normalizes the slope determined by the best-fit line of the SVV data included in interval I5 to a value with a negative 0.58 (i.e., -0.58).

[0071] Therefore, the hemodynamic monitor 10 can determine one or more normalized slopes of one or more best-fit lines for one or more corresponding defined time intervals of hemodynamic parameters. The hemodynamic monitor 10 uses the normalized slopes of one or more best-fit lines to determine a trend score associated with the hemodynamic parameters.

[0072] Figure 8L The illustration shows an example of how the hemodynamic monitor 10 applies weighting factors to each normalized slope of the best-fit line of SVV parameter data and aggregates the weighted normalized slopes to determine a fluid trend sub-score. Figure 8L As shown, the hemodynamic monitor 10 can apply weighting factors to each normalized slope of the best-fit line, such as by multiplying each normalized slope by the corresponding weighting factor (in... Figure 8L The diagram in the middle illustrates "window weight". For example, as shown... Figure 8L As shown, a weighting factor of 0.3 can be applied to the normalized slope value associated with interval I1 (i.e., the defined time interval including the previous minute of SVV data), a weighting factor of 0.2 can be applied to the normalized slope value associated with interval I2 (i.e., the defined time interval including the previous two minutes of SVV data), a weighting factor of 0.1 can be applied to the normalized slope value associated with interval I3 (i.e., the defined time interval including the previous three minutes of SVV data), a weighting factor of 0.05 can be applied to the normalized slope value associated with interval I4 (i.e., the defined time interval including the previous four minutes of SVV data), and a weighting factor of 0.02 can be applied to the normalized slope value associated with interval I5 (i.e., the defined time interval including the previous five minutes of SVV data).

[0073] It should be understood that, regarding Figure 8L The weighting factors described are merely illustrative examples, and the values ​​of such weighting factors may differ from those described above. Figure 8L The values ​​described in the examples. For example, the weighting factors applied by the hemodynamic monitor 10 can be the same or different weighting factors, and can be determined experimentally, for example, based on average (or otherwise aggregated) past patient data, such that the determined fluid trend sub-score is aligned with effective clinical treatment regarding known patient outcomes associated with the past patient data. In some examples, such as Figure 8L For example, normalized slope values ​​associated with more recent time intervals can be weighted to a greater extent than normalized slope values ​​associated with less recent time intervals.

[0074] like Figure 8L As further shown, the hemodynamic monitor 10 can aggregate weighted normalized slope values ​​according to, for example, Equation 1 above. Figure 8L In the example, the hemodynamic monitor 10 aggregates the weighted normalized slope values ​​to produce an example fluid trend sub-score with a value of 1.73.

[0075] Figure 8M The illustration shows the hemodynamic monitor 10 scoring fluid therapy (in... Figure 8M The figure in the middle (represented as "fluid score") is determined as a fluid amplitude sub-score (in... Figure 8M The diagram shows the "absolute fluid score" and the fluid trend sub-score (in...). Figure 8M The diagram shows an example of a combination of "fluid trend scores". Figure 8M In the example, hemodynamic monitor 10 determines the fluid amplitude sub-score (as mentioned above regarding...). Figure 8B The value described is 0.5 (i.e., based on the 10% SVV value at the initial evaluation point 84 and linearly interpolated between the lower limit amplitude threshold of the 7% SVV parameter and the upper limit amplitude threshold of the 13% SVV parameter).

[0076] The hemodynamic monitor 10 determines the fluid therapy score as the product of the fluid amplitude sub-score and the fluid trend sub-score, producing a fluid therapy score of 0.865. Figure 8M In the example, hemodynamic monitor 10 outputs a representation of the fluid therapy score as the value 87, although in other examples, hemodynamic monitor 10 may output different representations of the score. For example, hemodynamic monitor 10 may output a raw score (e.g., a value of 0.867), a rounded raw score (e.g., a value of 0.87, a value of 0.9, or other rounded scores), or other indications of the score. As further described above, in some examples, hemodynamic monitor 10 may output a representation of the score as a color-coded score, a symbolic representation of the score, or other representations of the score indicating the patient's predictive responsiveness to treatment.

[0077] Therefore, the hemodynamic monitor 10 implementing the technology of this disclosure can provide one or more scores predicting a patient's responsiveness to corresponding treatment, providing decision support to help clinicians or other medical personnel determine timely and effective therapeutic treatment for indicated hemodynamic conditions. As mentioned above, although Figures 8A-8M The example is a description of a fluid therapy score used to determine a patient's responsiveness to a therapeutically delivered fluid, but... Figures 8A-8M The technology is applicable to determining other treatment scores, such as the vasopressor treatment score predicting a patient's responsiveness to therapeutically delivered vasopressor drugs, and the inotropic drug treatment score predicting a patient's responsiveness to therapeutically delivered inotropic drugs.

[0078] Figure 9AThis is a graph illustrating a further example of an amplitude sub-score used to determine the correlation between the therapeutic intravenous delivery of fluid to a patient. (See diagram.) Figure 9A As shown, the hemodynamic monitor 10 can determine an amplitude sub-score associated with the therapeutic delivery of fluid to the patient based on any one or more of SVV, PPV, SVI, and SV. For example, as mentioned above regarding... Figure 8B Similarly described, the hemodynamic monitor 10 can score the fluid amplitude sub-scale (in) based on the SVV value. Figure 9A The figure in the middle (represented as "fluid absolute score") is determined as a normalized value.

[0079] like Figure 9A As further shown, the hemodynamic monitor 10 can determine a normalized value for the fluid amplitude sub-score based on the corresponding values ​​of any one or more of PPV, SVI, and SV. For example, as Figure 9A As shown, the hemodynamic monitor 10 can determine the fluid amplitude sub-score as a normalized value between a lower normalized threshold with a value of zero at a lower amplitude threshold of 7% PPV and an upper normalized threshold with a value of one at an upper amplitude threshold of 13% PPV. The hemodynamic monitor 10 can determine the fluid amplitude sub-score within a range of 40 ml / m 2 The upper limit of SVI has a lower limit normalized threshold with a value of zero at the upper limit amplitude threshold and at 30 ml / m 2 The SVI has a normalized value between a lower limit amplitude threshold with a value of one and an upper normalized threshold with a value of one. The hemodynamic monitor 10 can determine the fluid amplitude sub-score as a normalized value between a lower limit normalized threshold with a value of zero at the upper limit amplitude threshold of 80 ml SV and an upper normalized threshold with a value of one at the lower limit amplitude threshold of 60 ml SV. (As mentioned above...) Figure 8B The examples described similarly are about Figure 9A The described upper and lower bound normalization thresholds and upper and lower bound amplitude thresholds are illustrative only, and other normalization thresholds and amplitude thresholds are possible.

[0080] Figure 9B This is a chart illustrating an example of an amplitude sub-score used to determine the correlation between the administration of therapeutic intravenous inotropic drugs to a patient. (See above regarding...) Figure 8B and Figure 9A Similarly described (i.e., corresponding to determining the amplitude sub-score associated with the therapeutic delivery of fluid to the patient), the hemodynamic monitor 10 can be based on dP / dt max The values ​​of any one or more of CO and CI will be used to calculate the muscle strength drug amplitude sub-score (in Figure 9B The figure in the middle (representing the "absolute score of muscle strength medication") is determined as a normalized value. For example, as... Figure 9BAs shown, the hemodynamic monitor 10 can determine the muscle strength drug amplitude sub-score as dP / dt in the range of 700 mmHg / s. max The upper limit amplitude threshold has a lower limit normalized threshold with a value of zero and dP / dt at 400 mmHg / s. max The hemodynamic monitor 10 can determine the muscle strength drug amplitude sub-score as a normalized value between a lower limit normalized threshold with a value of zero at the upper limit amplitude threshold of CO in the range of 6 L / min and an upper limit normalized threshold with a value of one at the lower limit amplitude threshold of CO in the range of 4 L / min. The hemodynamic monitor 10 can also determine the muscle strength drug amplitude sub-score as a normalized value between a lower limit normalized threshold with a value of zero at the upper limit amplitude threshold of CO in the range of 3 L / min / m. 2 The upper limit of the CI has a lower limit of zero at the normalized threshold and at 2L / min / m 2 The CI has a normalized value between the upper and lower normalized thresholds, with a value of one. It should be understood that, regarding... Figure 9B The described upper and lower bound normalization thresholds and upper and lower bound amplitude thresholds are illustrative only, and other normalization thresholds and amplitude thresholds are possible.

[0081] Figure 9C This is a graph illustrating an example of an amplitude sub-score used to determine the vasopressor amplitude sub-score associated with the therapeutic intravenous delivery of vasopressor drugs to a patient. As described above, the hemodynamic monitor 10 can assign the vasopressor amplitude sub-score (in...) based on values ​​of any one or more of the SVR and SVRI. Figure 9C The figure in the middle shows the "absolute score of vasopressors" as a normalized value. For example, the hemodynamic monitor 10 can determine the vasopressor amplitude sub-score as ranging from 1100 dynes·second·cm. -5 The normalized value is between a lower normalized threshold with a value of zero at the upper limit amplitude threshold of the SVR and an upper normalized threshold with a value of one at the lower limit amplitude threshold of the SVR at 88 mmHg. The hemodynamic monitor 10 can determine the vasopressor amplitude sub-score in the range of 2200 dynes·second·cm. -5 ·m 2 The SVRI has a lower bound normalized threshold with a value of zero at the upper amplitude threshold and at 1600 dynes·second·cm. -5 ·m 2 The SVRI has a normalized value between the lower bound amplitude threshold and the upper bound normalized threshold, which is a value of one.

[0082] As in Figures 8A-8MSimilar to the example describing fluid therapy scoring, hemodynamic monitor 10 can use vasopressor amplitude sub-score and inotropic agent amplitude sub-score to determine one or more of vasopressor therapy scores and inotropic agent therapy scores. For example, hemodynamic monitor 10 can determine a vasopressor trend sub-score based on trend data derived from the patient's SVR parameter data (or SVRI parameter data) to produce vasopressor therapy as a combination of the vasopressor amplitude sub-score and the vasopressor trend sub-score. Hemodynamic monitor 10 can also determine a vasopressor therapy score based on the patient's dP / dt... max Trend data derived from parameter data (or CO parameter data or CI parameter data) determines the inotropic drug trend sub-score to generate an inotropic drug treatment score as a combination of the inotropic drug amplitude sub-score and the inotropic drug trend sub-score.

[0083] Therefore, as described in this paper, hemodynamic monitors can provide one or more scores predicting a patient's responsiveness to corresponding treatments, thereby reducing the information processing burden on attending physicians and providing them with decision support to deliver therapeutic treatments promptly and effectively in response to indicated hemodynamic conditions. The provided scores (determined not only by amplitude data but also by trend data of derived hemodynamic parameters) can help indicate a patient's future responsiveness to corresponding treatments, further enhancing the decision support provided by the corresponding scores.

[0084] Although the invention has been described with reference to one or more exemplary embodiments, those skilled in the art will understand that various changes can be made and elements can be substituted with equivalents without departing from the scope of the invention. Furthermore, many modifications can be made to adapt particular situations or materials to the teachings of the invention without departing from the basic scope of the invention. Therefore, it is intended that the invention be limited to the specific embodiments disclosed, but rather that the invention encompass all embodiments falling within the scope of the appended claims.

Claims

1. A method for monitoring arterial pressure in a patient and determining a first score and a second score, each of the first score and the second score predicting the patient's responsiveness to a corresponding treatment for a corresponding hemodynamic condition, the method comprising: Sensed hemodynamic data representing the patient's arterial pressure waveform is received via a hemodynamic monitor; The hemodynamic monitor derives amplitude and trend data of a first hemodynamic parameter indicating a first hemodynamic condition from the sensed hemodynamic data, wherein the trend data includes the trend of the first hemodynamic parameter over time. The hemodynamic monitor determines a first score that predicts the patient's responsiveness to the first treatment based on the amplitude data and trend data of the first hemodynamic parameter. The hemodynamic monitor derives amplitude and trend data of a second hemodynamic parameter indicating a second hemodynamic condition from the sensed hemodynamic data, wherein the trend data of the second hemodynamic parameter includes the trend of the second hemodynamic parameter over time; The hemodynamic monitor determines a second score, which predicts the patient's responsiveness to a second treatment, which is different from the first treatment, based on the amplitude and trend data of the second hemodynamic parameters. as well as The hemodynamic monitor outputs representations of the first score and the second score; The first hemodynamic parameter and the first treatment, and the second hemodynamic parameter and the second treatment are selected from the following options: a) The hemodynamic parameter is either systemic vascular resistance (SVR) or systemic vascular resistance index (SVRI), and the treatment is intravenous administration of a pressurizing drug to the patient; b) The hemodynamic parameter mentioned is the maximum rate of rise of arterial pressure, i.e., dP / dt. max The treatment involves intravenous administration of an inotropic drug to the patient, either cardiac output (CO) or cardiac index (CI). c) The hemodynamic parameters are one of stroke volume variation (SVV), pulse pressure variation (PPV), stroke volume (SV), or stroke volume index (SVI), and the treatment is intravenous administration of saline fluid to the patient.

2. The method of claim 1, wherein determining at least the first score or the second score based on the amplitude data and trend data of the corresponding first hemodynamic parameter or second hemodynamic parameter comprises: An amplitude sub-score is determined based on the amplitude data of the hemodynamic parameters; A trend sub-score is determined based on the trend data of the hemodynamic parameters; as well as The score is determined to be a combination of the magnitude sub-score and the trend sub-score.

3. The method of claim 2, wherein determining the score as a combination of the amplitude sub-score and the trend sub-score comprises determining the score as the product of the amplitude sub-score and the trend sub-score.

4. The method of claim 2, wherein determining the amplitude sub-score comprises determining the amplitude sub-score as a normalized value ranging between a lower normalized threshold at the lower amplitude threshold of the amplitude data of the hemodynamic parameter and an upper normalized threshold at the upper amplitude threshold of the amplitude data of the hemodynamic parameter.

5. The method of claim 4, wherein determining the amplitude sub-score as the normalized value includes interpolating between the lower normalized threshold and the upper normalized threshold in response to determining that the amplitude data of the hemodynamic parameter is greater than the lower amplitude threshold and less than the upper amplitude threshold.

6. The method of claim 2, wherein deriving the trend data of the hemodynamic parameters includes determining the slope of the best-fit line of the hemodynamic parameters associated with a defined time interval.

7. The method of claim 6, wherein determining the trend sub-score includes normalizing the slope of the best-fit line to determine the normalized slope of the best-fit line for the hemodynamic parameters associated with the defined time interval.

8. The method of claim 7, wherein determining the trend sub-score further comprises applying a weighting factor to the normalized slope of the best-fit line to determine the weighted normalized slope of the best-fit line for the hemodynamic parameters associated with the defined time interval.

9. The method of claim 2, wherein deriving the trend data of the hemodynamic parameters includes determining multiple slopes of multiple best-fit lines of the hemodynamic parameters associated with multiple defined time intervals.

10. The method of claim 1, further comprising: The hemodynamic monitor derives amplitude and trend data of a third hemodynamic parameter indicating a third hemodynamic condition from the hemodynamic data, wherein the trend data of the third hemodynamic parameter includes the trend of the third hemodynamic parameter over time; Based on the amplitude and trend data of the third hemodynamic parameter, the hemodynamic monitor determines a third score predicting the patient's response to a third treatment, which differs from both the first and second treatments; and The third score is output by the hemodynamic monitor; in: a) The first hemodynamic parameter is one of systemic vascular resistance (SVR) or systemic vascular resistance index (SVRI), and wherein the first treatment is intravenous administration of a vasopressor to the patient. b) The second hemodynamic parameter is the maximum rate of rise of arterial pressure, i.e., dP / dt. max The second treatment is either cardiac output (CO) or cardiac index (CI), and the second treatment is the intravenous administration of an inotropic drug to the patient. c) The third hemodynamic parameter is one of stroke volume variation (SVV), pulse pressure variation (PPV), stroke volume (SV), or stroke volume index (SVI), and the third treatment is intravenous administration of saline fluid to the patient.

11. A system for monitoring arterial pressure in a patient and determining a first score and a second score, each of the first score and the second score predicting the patient's responsiveness to a corresponding treatment for a corresponding hemodynamic condition, the system comprising: A hemodynamic sensor that generates hemodynamic data representing the patient's arterial pressure waveform; System memory, which stores the code for hemodynamic therapy scoring software; user interface; as well as A hardware processor, configured to execute the hemodynamic therapy scoring software code, to: From the hemodynamic data representing the patient's arterial pressure waveform, amplitude data and trend data of a first hemodynamic parameter indicative of a first hemodynamic condition are derived, wherein the trend data includes the trend of the first hemodynamic parameter over time; Based on the amplitude data and trend data of the first hemodynamic parameter, a first score is determined to predict the patient's response to the first treatment; From the hemodynamic data representing the patient's arterial pressure waveform, amplitude data and trend data of a second hemodynamic parameter indicative of a second hemodynamic condition are derived, wherein the trend data of the second hemodynamic parameter includes the trend of the second hemodynamic parameter over time; Based on the amplitude data and trend data of the second hemodynamic parameter, a second score is determined to predict the patient's response to the second treatment, which is different from the first treatment; as well as The user interface outputs representations of the first and second ratings; The first hemodynamic parameter and the first treatment, and the second hemodynamic parameter and the second treatment are selected from the following options: a) The hemodynamic parameter is either systemic vascular resistance (SVR) or systemic vascular resistance index (SVRI), and the treatment is intravenous administration of a pressurizing drug to the patient; b) The hemodynamic parameter mentioned is the maximum rate of rise of arterial pressure, i.e., dP / dt. max The treatment involves intravenous administration of an inotropic drug to the patient, either cardiac output (CO) or cardiac index (CI). c) The hemodynamic parameters are one of stroke volume variation (SVV), pulse pressure variation (PPV), stroke volume (SV), or stroke volume index (SVI), and the treatment is intravenous administration of saline fluid to the patient.

12. The system of claim 11, wherein the hardware processor is configured to execute the hemodynamic treatment scoring software code to determine at least the first score or the second score based on the amplitude data and the trend data of the corresponding first or second hemodynamic parameter: An amplitude sub-score is determined based on the amplitude data of the hemodynamic parameters; A trend sub-score is determined based on the trend data of the hemodynamic parameters; as well as The score is determined to be a combination of the magnitude sub-score and the trend sub-score.

13. The system of claim 12, wherein the hardware processor is configured to execute the hemodynamic treatment scoring software code to determine the score as the combination of the amplitude sub-score and the trend sub-score by determining the score as the product of the amplitude sub-score and the trend sub-score.

14. The system of claim 12, wherein the hardware processor is configured to execute the hemodynamic treatment scoring software code to determine the amplitude sub-score as a normalized value ranging between a lower limit normalized threshold at the lower limit amplitude threshold of the amplitude data of the hemodynamic parameter and an upper limit normalized threshold at the upper limit amplitude threshold of the amplitude data of the hemodynamic parameter.

15. The system of claim 12, wherein the hardware processor is configured to execute the hemodynamic treatment scoring software code to derive the trend data of the hemodynamic parameters by determining the slope of the best-fit line of the hemodynamic parameters associated with a defined time interval.

16. The system of claim 15, wherein the hardware processor is configured to execute the hemodynamic treatment scoring software code to determine the trend sub-score by normalizing the slope of the best-fit line to determine the normalized slope of the best-fit line of the hemodynamic parameters associated with the defined time interval.

17. The system of claim 16, wherein the hardware processor is configured to execute the hemodynamic treatment scoring software code to determine the trend sub-score by applying a weighting factor to the normalized slope of the best-fit line to determine the weighted normalized slope of the best-fit line of the hemodynamic parameters associated with the defined time interval.

18. The system of claim 12, wherein the hardware processor is configured to execute the hemodynamic treatment scoring software code to derive the trend data of the hemodynamic parameters by determining multiple slopes of multiple best-fit lines of the hemodynamic parameters associated with multiple defined time intervals.

19. The system of claim 11, wherein the hardware processor is further configured to execute the hemodynamic treatment scoring software code to: From the hemodynamic data, amplitude data and trend data of a third hemodynamic parameter indicating a third hemodynamic condition are derived, wherein the trend data of the third hemodynamic parameter includes the trend of the third hemodynamic parameter over time; A third score is determined based on the amplitude data and trend data of the third hemodynamic parameter to predict the patient's response to a third treatment, wherein the third treatment is different from both the first and second treatments; and The third rating is displayed via the user interface. in: a) The first hemodynamic parameter is one of systemic vascular resistance (SVR) or systemic vascular resistance index (SVRI), and wherein the first treatment is intravenous administration of a vasopressor to the patient. b) The second hemodynamic parameter is the maximum rate of rise of arterial pressure, i.e., dP / dt. max The second treatment is either cardiac output (CO) or cardiac index (CI), and the second treatment is the intravenous administration of an inotropic drug to the patient. c) The third hemodynamic parameter is one of stroke volume variation (SVV), pulse pressure variation (PPV), stroke volume (SV), or stroke volume index (SVI), and the third treatment is intravenous administration of saline fluid to the patient.

Citation Information

Patent Citations

  • Use of aortic pulse pressure and flow in bedside hemodynamic management

    CN1652718A